- English (USA)
- English (UK)
- English (India)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Gan & Lee Pharmaceuticals Co Ltd (603087)
Gan & Lee Pharmaceuticals Co Ltd stock price live, this page displays SS 603087 stock exchange data. View the 603087 premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Gan & Lee Pharmaceuticals Co Ltd real time stock price chart below.
What Is the Gan & Lee Pharmaceuticals Co Ltd Stock Price Today?
The Gan & Lee Pharmaceuticals Co Ltd stock price today is 68.43.
What Is the Stock Symbol for Gan & Lee Pharmaceuticals Co Ltd?
The stock symbol for Gan & Lee Pharmaceuticals Co Ltd is "603087."
What Stock Exchange Does Gan & Lee Pharmaceuticals Co Ltd Trade On?
Gan & Lee Pharmaceuticals Co Ltd is listed and trades on the Shanghai stock exchange.
Is Gan & Lee Pharmaceuticals Co Ltd a Good Stock to Buy?
Determining whether Gan & Lee Pharmaceuticals Co Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the 603087 quote. (ISIN: CNE100003ZH1)
What Is the Gan & Lee Pharmaceuticals Co Ltd Stock Price Today?
The Gan & Lee Pharmaceuticals Co Ltd stock price today is 68.43.
What Is the Stock Symbol for Gan & Lee Pharmaceuticals Co Ltd?
The stock symbol for Gan & Lee Pharmaceuticals Co Ltd is "603087."
What Stock Exchange Does Gan & Lee Pharmaceuticals Co Ltd Trade On?
Gan & Lee Pharmaceuticals Co Ltd is listed and trades on the Shanghai stock exchange.
Is Gan & Lee Pharmaceuticals Co Ltd a Good Stock to Buy?
Determining whether Gan & Lee Pharmaceuticals Co Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the 603087 quote. (ISIN: CNE100003ZH1)
Shanghai
Currency in CNY
68.43
-3.44(-4.79%)
Closed·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
68.10
71.70
52 wk Range
51.51
82.25
Earnings results expected in 5 days
1/2
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
68.1071.70
52 wk Range
51.5182.25
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(1.46%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(1.46%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
603087 Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Neutral
Analysts Sentiment
Strong Buy
Price Target
72.50
Upside
+5.95%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Impressive gross profit margins
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell
Analyst Ratings
3 Buy
0 Hold
0 Sell
Ratings:
3 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 72.50
(+5.95% Upside)
Earnings
Latest Release
Apr 23, 2026
EPS / Forecast
0.32 / 0.40
Revenue / Forecast
878M / 985.26M
Compare 603087 to Peers and Sector
Metrics to compare | 603087 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship603087PeersSector | |
|---|---|---|---|---|
P/E Ratio | 40.8x | 35.8x | −0.3x | |
PEG Ratio | 1.75 | 0.65 | 0.00 | |
Price/Book | 3.5x | 2.6x | 2.6x | |
Price / LTM Sales | 10.6x | 6.4x | 3.1x | |
Upside (Analyst Target) | 5.9% | 31.6% | 47.6% | |
Fair Value Upside | Unlock | 17.8% | 5.6% | Unlock |
Gan & Lee Pharmaceuticals., a biopharmaceutical company, engages in the development, production, and commercialization of insulin analogs and medical devices in China. Its products include Basalin, an insulin glargine injection; Prandilin, an insulin lispro injection; Prandilin 25, an insulin lispro mix 75/25 injection; Rapilin, an insulin aspart injection; Rapilin 30, an insulin aspart 30 injection; and Similin 30, a mixed protamine human insulin injection. The company also offers GanleePen, an insulin injection device; and GanleeFine, an insulin pen needle. The company was formerly known as Beijing Gan & Lee Biotechnology Co., Ltd. and changed its name to Gan & Lee Pharmaceuticals. in April 2005. Gan & Lee Pharmaceuticals. was founded in 1998 and is headquartered in Beijing, the People’s Republic of China.
Ownership
Ownership Overview
Top Holders
FAQ
What Is the Gan Lee Pharmaceuticals (603087) Stock Price Today?
The Gan Lee Pharmaceuticals stock price today is 68.43 CNY.
What Stock Exchange Does Gan Lee Pharmaceuticals Trade On?
Gan Lee Pharmaceuticals is listed and trades on the Shanghai Stock Exchange.
What Is the Stock Symbol for Gan Lee Pharmaceuticals?
The stock symbol for Gan Lee Pharmaceuticals is "603087."
Does Gan Lee Pharmaceuticals Pay Dividends? What’s The Current Dividend Yield?
The Gan Lee Pharmaceuticals dividend yield is 1.46%.
What Is the Gan Lee Pharmaceuticals Market Cap?
As of today, Gan Lee Pharmaceuticals market cap is 40.73B CNY.
What Is Gan Lee Pharmaceuticals's Earnings Per Share (TTM)?
The Gan Lee Pharmaceuticals EPS (TTM) is 1.73.
When Is the Next Gan Lee Pharmaceuticals Earnings Date?
Gan Lee Pharmaceuticals will release its next earnings report on Aug 26, 2026.
From a Technical Analysis Perspective, Is 603087 a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Neutral.
How Many Times Has Gan Lee Pharmaceuticals Stock Split?
Gan Lee Pharmaceuticals has split 1 times.
How Many Employees Does Gan Lee Pharmaceuticals Have?
Gan Lee Pharmaceuticals has 5309 employees.
What is the current trading status of Gan Lee Pharmaceuticals (603087)?
As of Aug 21, 2026, Gan Lee Pharmaceuticals (603087) is trading at a price of 68.43 CNY, with a previous close of 71.87 CNY. The stock has fluctuated within a day range of 68.10 CNY to 71.70 CNY, while its 52-week range spans from 51.51 CNY to 82.25 CNY.
What Is Gan Lee Pharmaceuticals (603087) Price Target According to Analysts?
The average 12-month price target for Gan Lee Pharmaceuticals is 72.50 CNY, with a high estimate of 77 CNY and a low estimate of 68 CNY. 3 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +5.95% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.